Abstract
The level of antigen loading can impact on the capacity for dendritic cells (DC) to activate T cell responses. Several different approaches to adenoviral (Ad)-based transduction were therefore assessed for their effect on both transgene expression and T cell activation. While a conventional E1(-)/E3Delta Ad vector (Ad/GFP) produced a concentration-dependent expression of GFP, a modified vector expressing Arginine-Glycine-Aspartic Acid (RGD) sequence on its fiber knob (Ad-RGD/GFP) enhanced transgene expression by 9-20-fold at each MOI. The addition of centrifugal force (2000xg) during DC transduction with Ad/GFP also increased expression up to 20-fold. However, combining centrifugation with the Ad-RGD/GFP vector produced no effect on transduction rate and only a 1.5- to 2-fold increase in GFP expression, suggesting overlapping mechanisms of action. Consistent with this, exogenous RGD peptide blocked transduction regardless of the vector used, or the addition of centrifugal force, and transduction was primarily limited to DC expressing the CD51 integrin receptor. Ad vectors expressing ovalbumin (OVA) were used to assess transduced DC for their capacity to activate OVA-specific T cells. We observed a significant relationship betwe...Continue Reading
References
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·V BronteN P Restifo
Aug 24, 1999·Gene Therapy·P ReynoldsD Curiel
Aug 2, 2000·Gene Therapy·E A HirschowitzD E Doherty
Dec 19, 2000·Journal of Virology·A SarukhanK Jooss
Mar 10, 2001·Human Gene Therapy·N NishimuraS Sone
Jun 1, 2001·Journal of Immunological Methods·N NishimuraS Sone
Jun 15, 2001·Gene Therapy·H MizuguchiT Hayakawa
Oct 20, 2001·Critical Reviews in Immunology·M Gunzer, S Grabbe
Feb 28, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert J KorstRonald G Crystal
Apr 4, 2002·Blood·Saroj K BasakMichael D Roth
Apr 30, 2003·Human Gene Therapy·Andrei N VarnavskiJames M Wilson
Apr 30, 2003·Cancer Gene Therapy·Naoki OkadaAkira Yamamoto
Sep 6, 2003·Journal of Immunological Methods·George C MaynePrue H Hart
Oct 15, 2003·Journal of Virology·Natalya BelousovaVictor Krasnykh
Jan 17, 2004·Cancer Gene Therapy·Elisabeth H SlagerMarieke Griffioen
Feb 14, 2004·Journal of Virology·Stefan WorgallRonald G Crystal
Jul 29, 2004·Viral Immunology·Saroj K BasakMichael D Roth
Aug 6, 2004·Gene Therapy·A HaruiS K Basak
Oct 27, 2004·Blood Reviews·Volker L ReichardtLothar Kanz
Apr 12, 2005·Journal of Clinical Immunology·Sylvia AdamsNina Bhardwaj
Apr 28, 2005·Current Gene Therapy·Qiaohua WuJim Xiang
Jun 15, 2005·Annual Review of Biochemistry·Inder M Verma, Matthew D Weitzman
Jun 29, 2005·Transplant Immunology·Matjaz JerasUrska Repnik
Jul 12, 2005·Oncology·Masaki NakamuraHiroki Yamaue
Sep 24, 2005·Scandinavian Journal of Immunology·V SalucciN La Monica
Citations
Jun 10, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Airi HaruiMichael D Roth
Apr 6, 2011·PloS One·Sadhak SenguptaMaciej S Lesniak
Apr 25, 2014·Toxins·Juliette K TinkerKenneth A Cornell
Jun 28, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elena MataRosa M Hernández
Apr 24, 2007·Journal of Applied Microbiology·H A LankesS Dewhurst